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Perspectives on: SGP Symposium on Mitochondrial Physiology and Medicine

Mitochondria take center stage
Shey-Shing Sheu,1 Robert T. Dirksen,2 and Edward N. Pugh Jr.3
1

The Journal of General Physiology

Department of Medicine, Center for Translational Medicine, Jefferson Medical College, Thomas Jefferson University,
Philadelphia, PA 19107
2
Department of Pharmacology and Physiology, University of Rochester Medical Center, Rochester, NY 14642
3
Center for Neuroscience, University of California, Davis, Davis, CA 95616

Mitochondria are the ubiquitous power units of animal
cells, responsible for “oxphos,” the aerobic synthesis of
most of the ATP that serves as the common coin of cellular metabolism. To perform their primary task of oxidative phosphorylation and to manage many secondary
tasks, mitochondria use more than 1,000 proteins, of
which fewer than 100 are involved directly in oxidative
phosphorylation. The “secondary” tasks mitochondria
perform include their own maintenance, calcium regulation and signaling, lipid synthesis, and acting as gatekeepers for programmed cell death. Catalyzed by the
advances in knowledge and technology that underlie
great progress in all areas of cell biology, mitochondrial
physiology has been undergoing a renaissance. In this
special issue of the Journal we highlight some examples
of this renaissance, offering a series of Perspectives on
Mitochondria. The purpose of the Perspectives in General Physiology is to provide a forum where scientific
uncertainties or controversies are discussed in an authoritative, yet open manner. This series had its origin
in the 65th Annual Symposium of the Society of General Physiologists on “Mitochondrial Physiology and
Medicine,” which took place in September 2011 in
Woods Hole, MA. The meeting was organized by SheyShing Sheu (Thomas Jefferson University) along with
a committee comprising leaders in mitochondrial
research, including Robert Balaban (NHLBI), Paolo
Bernardi (University of Padova), Robert Dirksen (University of Rochester), Roberta Gottlieb (San Diego State
University), Gyorgy Hajnóczky (Thomas Jefferson University), and Brian O’Rourke (Johns Hopkins University). A summary of the meeting was recently published
(Sheu et al., 2011).
Mitochondrial proteomes

Mitochondria contain more than 1,000 proteins, of
which only 13 are encoded by mitochondrial DNA. In
their Perspective, Zhang et al. summarize recent advances in mitochondrial proteomics, including quantifying “subproteomes” of the mitochondria devoted to
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different cellular functions. The proteomes of mitochondria in various tissues (e.g., heart, muscle, brain)
differ, and proteomic variation also causes or is associated with disease. Substantial differences, for example,
exist between heart and liver mitochondrial proteomes
that can be directly related to tissue-specific needs. Of
particular medical importance are the distinct proteomic features of mitochondria from healthy and diseased cardiac myocytes. Another important and rapidly
developing aspect of mitochondrial proteomics is the
characterization of posttranslational modifications, some
of which are dynamic and may play critical roles in modulating oxphos function on a subsecond scale (see next
section). The key challenge, as articulated by Zhang
et al., will be to translate the burgeoning mitochondrial
proteomic databases into resources that can be readily
tapped to advance our understanding of physiological
function and pathophysiology.
Metabolic homeostasis of the heart

Nothing better illustrates the amazing capacity of mitochondria to meet the energy demands of tissue than
their ability to power the cardiac contraction cycle
throughout life, including workload increases of up to
10-fold during surges in sympathetic activity, such as
those that accompany the “fight or flight response.”
Mitochondria perform this feat with very little change
in the steady-state concentrations of key metabolites
such as ATP, ADP, Pi, and NADH. A.V. Hill (1950) first
noted the challenge posed by these facts, which he
called “metabolic homeostasis.” In his Perspective,
Robert Balaban takes up Hill’s challenge. Balaban marshals evidence that posttranslational modifications of
the F1F0 ATP synthase may underlie a 10-fold modulation of the maximum rate of ATP production (qATPmax),
and that calcium in the mitochondrial matrix is a major
regulator of qATPmax. These ideas comprise an important (although challenging to test) hypothesis that ties
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together several key aspects of mitochondrial physiology,
including the roles of variations in matrix calcium over
time and of matrix proteins regulated by calcium.
New insights from mitochondrial pH measurements

As articulated in Mitchell’s chemiosmotic theory, ATP
synthesis in mitochondria is driven by the proton motive force, which consists of the chemical gradient for
protons (pHm) and the mitochondrial membrane
potential (m). Measurement of pHm has been a
foundation of research in mitochondrial physiology.
However, classical measurements were performed in
bulk suspensions, disconnecting mitochondria from
the milieu of the living cell, in which many natural and
signal-dependent variations in pHi, Ca2+, and metabolites to which mitochondria are sensitive occur. Genetically encoded (optogenetic) pH probes that promise to
fill many gaps in the understanding of the chemiosmotic mechanism in living cells have recently been
developed. In their Perspective, Santo-Domingo and
Demaurex summarize recent research with mitochondrially targeted optogenetic pH probes, and, in particular, work they have done with a very promising probe,
mito-SypHer. Using this probe they have observed spontaneous increases in pHm elevations that coincided with
decreases in m in single mitochondria. Santo-Domingo
and Demaurex propose that these spontaneous alkalizations of the mitochondrial matrix reflect intrinsic
properties of the mitochondrial proton circuit that
function to stabilize the proton motive force with opposing changes in m and pHm, and summarize the
evidence that this stabilization process involves several
distinct exchangers and symporters.
Superoxide flashes: Quantal production of reactive oxygen
species (ROS)

Studying mitochondrial production of ROS has been
challenging because of the limited methods capable of
real-time monitoring of ROS levels in living cells and in
situ. Recently, circularly permuted yellow fluorescent
protein has been shown to specifically respond to superoxide. When targeted to the mitochondrial matrix, this
probe detects bursts of superoxide production, called
mitochondrial superoxide flashes (mSOFs), in individual mitochondria of intact quiescent cells. The Perspective of Wei and Dirksen provides an updated assessment
of the mechanisms underlying mSOF generation and
raises several controversies regarding the generation of
mSOFs, including the relationship between mSOFs and
pHm transients, the molecular identity of the large pore
channel that opens during a flash event, and the sequence of events between pore opening and mSOF
generation. Both mSOF and pHm signals require intact
electron transport chain activities, because inhibition of
any one of the electron transport complexes results in
the abolition of the signals. Although future experiments
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will be needed to resolve the relationship between
pHm transients and superoxide flashes, and their
role(s) in regulating mitochondrial energy and ROS
generation, both signals hold much promise in
revealing dynamic details of mitochondrial function in
living cells.
Mitochondrial calcium transport

The pivotal role of Ca2+ in regulating mitochondrial
function and dysfunction is well recognized. The dogma
for the mechanism of mitochondrial Ca2+ influx has
been that it is determined primarily by the mitochondrial Ca2+ uniporter (MCU), whose molecular identity
was recently revealed (Baughman et al., 2011; De Stefani
et al., 2011). Several studies have identified additional
Ca2+ uptake pathways, including a rapid mode of uptake and the highly conserved mitochondrial protein
leucine-zipper-EF-hand–containing transmembrane
protein 1 (LETM1), which exhibit different Ca2+ affinity, kinetics, and pharmacology from the MCU. The
Perspective by O-Uchi et al. examines recent studies
that have attempted to uncover the molecular identities
of mitochondrial Ca2+ influx mechanisms using genetic
manipulations, including small interfering RNA. O-Uchi
et al. argue that it is reasonable to expect that different
tissues may regulate mitochondrial Ca2+ influx in different fashions, with different combinations and expression
ratios of these channels and transporters, and point to
studies that will clarify the diversity of Ca2+ influx mechanisms, explain how these Ca2+ transporters are regulated by signaling molecules, and identify their distinct
physiological functions and pathologies.
A hotly debated issue is whether LETM1 acts as a high
affinity mitochondrial Ca2+ influx mechanism. The Perspective by Nowikovsky et al. summarizes current
understanding of the molecular nature and of the
physiology and pathophysiology of LETM1. LETM1 encodes a mitochondrial protein conserved throughout
eukaryotes, both animals and plants. Its deletion is embryonic lethal, and LETM1 mutations underlie the seizure disorder known as Wolf–Hirschhorn syndrome.
The protein was identified first as a mitochondrial
K+–H+ antiporter, but has since been argued to function
as a Ca2+–H+ antiporter by Jiang et al. (2009). Nowikovsky
et al. make the case that the normal electrochemical
gradients for H+ and Ca2+ would not allow LETM1 to act
as a Ca2+ influx mechanism, but rather that the driving
forces under physiological conditions favor LETM1
serving as a Ca2+ efflux rather than influx mechanism.
Shape changing: Role of morphology in
mitochondrial function

The idea that mitochondrial morphology is also a key
regulator of mitochondrial function has recently gained
much attention. The Perspective by Galloway and Yoon
summarizes the current understanding of the interplay

between mitochondrial form and function, with a specific
focus on how disturbances of this interaction lead to metabolic disease. This Perspective highlights the dynamic
nature of the cross talk signaling between mitochondrial shape and metabolic activity. Well-orchestrated
mitochondrial fission, fusion, and molecular motor–
based movement are necessary to ensure healthy bioenergetics homeostasis.
Calcium buffering and calcium in cell death

The JGP is also publishing several primary articles involving research on mitochondria presented at the 2011
SGP Symposium. Two of these deal with calcium influx
into mitochondria and its role in triggering cell death.
In work presented in this issue, Wei et al. thoroughly
characterized two distinct modes of Ca2+ uptake in cardiac mitochondria, “MCUmode1” and “MCUmode2.” Mode 1
has a relatively low capacity, is engaged by small (0.1–
0. 2-µM) increases in Ca2+, is completely inhibited by
only relatively high levels (1 µM) of Ruthenium red
(Ru360), and triggers relatively large changes in matrix
free calcium. In contrast, mode 2 is responsible for the
bulk of calcium transport for external calcium in the
range of 2–10 µM, is inhibited by 0.1 µM Ru360, and is
associated with very small changes in matrix free calcium owing to very high buffering. The data and analyses presented in this article support the conclusion that
mode 1 calcium transport functions as a signal, perhaps
to dynamically modulate oxidative phosphorylation (see
Perspective by Balaban), whereas mode 2 is associated
with a high capacity Ca2+-buffering function. The investigation of Wei et al. also indicates that the trigger for
activation of the mitochondrial permeability transition
pore (mPTP) is unlikely to be free matrix Ca2+ itself, but
could be a downstream byproduct of total mitochondrial Ca2+ loading, a conclusion that dovetails nicely
with work in another paper recently published in the
JGP, by Seidlmayer et al. (2012).
Seidlmayer et al. (2012) quantified the inorganic
polyphosphate (polyP) content of mitochondria (300
pmol/mg of protein) in rabbit ventricular myocytes and
manipulated polyP levels by means of a mitochondrially
targeted polyphosphatase. Excess accumulation of Ca2+
in mitochondria is a key factor in triggering mPTP
opening (and subsequent apoptosis) and consequent
tissue damage such as occurs during cardiac ischemia
reperfusion injury. Seidlmayer et al. (2012) found that
depletion of polyP inhibited mPTP opening without
affecting the matrix free calcium, and put forward the
hypothesis that stable complexes of calcium with polyP
act as triggers for mPTP opening. This is an important
advance, which make a critical link between mitochondrial calcium influx, calcium buffering by polyP,
and activation of the mPTP.



Mitochondrial antioxidants and scavenging of ROS

ROS are normally generated at very low levels by the
mitochondrial respiratory chain but increase under
conditions of stress, and can ultimately lead to tissue
damage. In this issue, Aon et al. performed experiments
and theoretical analyses to assess the relative contribution of glutathione (GSH) and thioredoxin (Trx), the
two principal antioxidants in mitochondria, to the scavenging of H2O2, a major ROS. Their results show that
the reactions governing the concentrations GSH and
Trx are essential to maintaining minimal emission of
H2O2 during high level respiration, and that the reactions maintaining GSH and Trx work in close concert
toward achieving this end.
Letters to the editor related to these Perspectives will
be published in the September 2012 issue of the Journal.
Letters to the editor should be received no later than
Monday, July 16, 2012. The letters may be no longer
than two printed pages (approximately six doublespaced pages) and will be subject to editorial review.
They may contain no more than one figure, no more
than 15 references, and no significant references to unpublished work (and may not include supplemental
material). Letters should be prepared according to the
Journal’s instructions and can be submitted electronically at http://www.jgp.org. After the letters to the editor have been published, further responses are limited
to full manuscripts.
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